Hepatitis Testing/Diagnosis Market is expected to reach USD 4.4 billion by 2031 | Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US)

The global hepatitis testing/diagnosis market was valued at USD 2.6 billion in 2021 and it is anticipated to reach up to USD 4.4 billion by 2031, at a CAGR of 5.5% during the forecast period.

Get Access to A Free Sample Copy of Our Latest Report - https://www.globalinsightservices.com/request-sample/GIS10295

The goal of hepatitis diagnosis is to identify the genotype of the infection that is causing the condition. The optimal course of treatment for the patient can be chosen based on the hepatitis diagnosis. In order to distinguish between different hepatitis viruses, it is crucial to make a diagnosis of the illness. Inflammation in the liver is the primary cause of hepatitis. Different forms of the hepatitis virus, including Hepatitis A, B, and C, are recognized. Blood tests are used to identify the presence of hepatitis disease. Testing bodily proteins or genetic material that is a component of the virus can also be used to identify hepatitis.

Market Trends and Drivers

Despite substantial advancements in treatment options, immunization coverage, and public awareness, hepatitis remains a serious public health concern with a high prevalence rate worldwide. The most common hepatitis forms, B and C, are associated with greater fatality rates. According to estimates, 296 million and 58 million persons, respectively, had chronic HBV and HCV infections in 2019. Compared to industrialized countries, hepatitis is more common in poor nations. Similarly, the biotechnology and biopharmaceutical industries have a significant demand for immunoassay equipment and supplies.

Report Overview- https://www.globalinsightservices.com/reports/hepatitis-testing-diagnosis-market

Therefore, over the forecast period, the expansion of these industries is anticipated to boost the expansion of the hepatitis testing market. The expansion of the end-user market in these sectors has prompted numerous businesses to introduce new products and make investments in the development of cutting-edge products. Since immunoassays are used throughout the production process, from product development and manufacturing to quality control, this is regarded as a promising sign for the market's expansion.

Major Players in the Global Hepatitis Testing/Diagnosis Market

The key players studied in the market are F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), QIAGEN (Netherlands), bioMérieux SA (France), DiaSorin S.P.A. (Italy), Ortho Clinical Diagnostics (US), MedMira Inc. (Canada), and Fujirebio US, Inc. (Japan) among others.

Get a customized scope to match your need, ask an expert - https://www.globalinsightservices.com/request-customization/GIS10295

COVID-19 Impact

Due to fewer hospital visits caused by the COVID-19 outbreak, the market for hepatitis testing suffered. Healthcare systems are under a lot of stress as a result of the pandemic. To reduce the disease's spread and save money for COVID-19 sufferers, healthcare institutions and clinicians were told to avoid performing elective surgical procedures and physical exams. As a result, the testing volume at numerous clinical laboratories for hepatitis testing rapidly decreased. The American Journal of Preventive Medicine reports that hepatitis C testing has significantly decreased across the US. The study's findings, "Decreases in Hepatitis C Testing and Treatment," HCV antibody tests that were suggested by the COVID-19 Pandemic decreased by 59 percent in April 2020 before increasing to a 6 percent decline in July 2020. In contrast, the number of HCV RNA-positive tests dropped by 62% in March 2020 and 39% in July 2020.

Global Hepatitis Testing/Diagnosis Market Segmentation

By Disease Type

Hepatitis B
Hepatitis C
Other Hepatitis

By Technology

Enzyme-Linked Immunosorbent Assay (ELISA)
Rapid Diagnostic Tests (RDT)
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Other Technologies

By End User

Hospital & Diagnostic Laboratories
Blood Banks
Other End Users

Buy Now - https://www.globalinsightservices.com/checkout/single_user/GIS10295

With Global Insight Services, you receive:

10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

New Report Published by Global Insight Services : https://www.globalinsightservices.com/reports/hydrogen-projects-database/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

This release was published on openPR.